Skip to main content Accessibility help
×
Home

Outbreak of Carbapenem-Resistant Enterobacteriaceae at a Long-Term Acute Care Hospital: Sustained Reductions in Transmission through Active Surveillance and Targeted Interventions

  • Amit S. Chitnis (a1) (a2), Pam S. Caruthers (a3), Agam K. Rao (a1) (a2), JoAnne Lamb (a4), Robert Lurvey (a1), Valery Beau De Rochars (a2) (a5), Brandon Kitchel (a1), Margarita Cancio (a3), Thomas J. Török (a5) (a6), Alice Y. Guh (a1), Carolyn V. Gould (a1) and Matthew E. Wise (a1)...

Abstract

Objective.

To describe a Klebsiella pneumoniae carbapenemase (KPC)–producing carbapenem-resistant Enterobacteriaceae (CRE) outbreak and interventions to prevent transmission.

Design, Setting, and Patients.

Epidemiologic investigation of a CRE outbreak among patients at a long-term acute care hospital (LTACH).

Methods.

Microbiology records at LTACH A from March 2009 through February 2011 were reviewed to identify CRE transmission cases and cases admitted with CRE. CRE bacteremia episodes were identified during March 2009–July 2011. Biweekly CRE prevalence surveys were conducted during July 2010–July 2011, and interventions to prevent transmission were implemented, including education and auditin? of staff and isolation and cohorting of CRE patients with dedicated nursing staff and shared medical equipment. Trends were evaluated using weighted linear or Poisson regression. CRE transmission cases were included in a case-control study to evaluate risk factors for acquisition. A real-time polymerase chain reaction assay was used to detect the blaKPC gene, and pulsed-field gel electrophoresis was performed to assess the genetic relatedness of isolates.

Results.

Ninety-nine CRE transmission cases, 16 admission cases (from 7 acute care hospitals), and 29 CRE bacteremia episodes were identified. Significant reductions were observed in CRE prevalence (49% vs 8%), percentage of patients screened with newly detected CRE (44% vs 0%), and CRE bacteremia episodes (2.5 vs 0.0 per 1,000 patient-days). Cases were more likely to have received β-lactams, have diabetes, and require mechanical ventilation. All tested isolates were KPC-producing K. pneumoniae, and nearly all isolates were genetically related.

Conclusion.

CRE transmission can be reduced in LTACHs through surveillance testing and targeted interventions. Sustainable reductions within and across healthcare facilities may require a regional public health approach.

Infect Control Hosp Epidemiol 2012;33(10):984-992

Copyright

Corresponding author

1600 Clifton Road, MS A-24, Atlanta, GA 30333 (amit.chitnis@cdph.ca.gov)

References

Hide All
1.Richet, HM, Mohammeed, J, McDonald, LC, Jarvis, WR. Building communications networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis 2001;7:319322.
2.Pitout, JD, Laupland, KB. Extended spectrum β-lactamase-producing Enterobacteriaceae: an emerging public health concern. Lancet Infect Dis 2008;8:159166.
3.Patel, G, Huprikar, S, Factor, SH, Jenkins, SG, Calfee, DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29:10991106.
4.Schwaber, MJ, Klarfeld-Lidji, S, Navon-Venezia, S, Schwartz, D, Leavitt, A, Carmeli, Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized patients and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:10281033.
5.Queenan, AM, Bush, K. Carbapenemases: the versatile β-lacta-mases. Clin Microbiol Rev 2007;20:440458.
6.Woodford, N, Tierno, PM Jr, Young, K, et al.Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-latctamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004;48:47934799.
7.Bratu, S, Landman, D, Haag, R, et al.Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotics armamentarium. Arch Intern Med 2005;165:14301435.
8.Nadkarni, AS, Schliep, T, Khan, L, Zeana, CB. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Am J Infect Control 2009; 37:121126.
9.Munoz-Price, LS, De La Cuesta, C, Adams, S, et al.Successful eradication of a monocolonal strain of Klebsiella pneumonia during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 2010;31:10741077.
10.Kontopoulou, K, Protonotariou, E, Vasilakos, K, et al.Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to Colistin. J Hosp Infect 2010;76:7073.
11.Marchaim, D, Chopra, T, Pogue, JM, et al.Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother 2011;54:50995104.
12.Endimiani, A, Depasquale, JM, Forero, S, et al.Emergence of bla KPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009;64:11021110.
13.Perez, F, Endimiani, A, Ray, AJ, et al.Carbapenem-resistant Aci-netobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 2010;65:18071818.
14.Won, SY, Munoz-Price, LS, Lolans, K, et al.Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011;53:532540.
15.Munoz-Price, LS, Hayden, MK, Lolans, K, et al.Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in a long-term acute care hospital. Infect Control Hosp Epidemiol 2010;31:341347.
16.Medicare Payment Advisory Commission. Report to the Congress: Medicare Payment Policy, http://www.medpac.gov/documents/mar11_entirereport.pdf. Published 2011. Accessed April 11, 2012.
17.Munoz-Price, LS. Long-term acute care hospitals. Clin Infect Dis 2009;49:438443.
18.Centers for Disease Control and Prevention. Laboratory Protocol for Detection of Carbapenem-Resistant or Carbapenemase-Producing, Klebsiella Spp. and E. coli for Rectal Swabs, http://www.cdc.gov/HAI/pdfs/labSettings/Klebsiella_or_Ecoli.pdf. Accessed April 11, 2012.
19.Clinical and Laboratory and Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 18th Informational Supplement. CLSI document M100-S18. Wayne, PA: CLSI, 2008.
20.Centers for Disease Control and Prevention. Multiplex Real-Time PCR Detection of Klebsiella pneumoniae Carbapenemase (KPC) and New Delhi Metallo-β-lactamase (NDM-1). http://www.cdc.gov/HAI/pdfs/labSettings/KPC-NDM-protocol-2011.pdf. Accessed April 11, 2012.
21.Ribot, EM, Fair, MA, Gautom, R, et al.Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli 0157:H7, Salmonella, and Shigella for PulseNet. Food-borne Pathog Dis 2006;3:5967.
22.Schaberg, DR, Weinstein, RA, Stamm, WE. Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis 1976;133:363366.
23.Yoon, HJ, Choi, JY, Park, YS, et al.Outbreak of Serratia marcescens bacteriuria in a neurosurgical intensive care unit of a tertiary care teaching hospital: a clinical, epidemiologic, and laboratory perspective. Am J Infect Control 2005;33:595601.
24.Otter, JA, Yezli, S, French, GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011;32:687699.
25.Centers for Disease Control and Prevention. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256260.
26.Schwaber, MJ, Lev, B, Israeli, A, et al.Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumonia in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848852.
27.Falgas, ME, Rafailidis, PI, Kofteridis, D, et al.Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case-control study. J Antimicrob Chemother 2007;60:11241130.
28.Patel, N, Harrington, S, Dihmess, A, et al.Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother 2011;66:16001608.
29.Weintrob, AC, Roediger, MP, Barber, M, et al.Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010;31:330337.

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed